| P50 | author | Gerome Breen | Q47502400 |
| | John P Quinn | Q41818693 |
| P2093 | author name string | Vivien J Bubb | |
| | Alix Warburton | |
| P2860 | cites work | Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 |
| | The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia | Q48140110 |
| | Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies. | Q51927765 |
| | MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 |
| | The schizophrenia risk gene product miR-137 alters presynaptic plasticity. | Q27312392 |
| | The structure of haplotype blocks in the human genome | Q27860500 |
| | Genome-wide association study identifies five new schizophrenia loci | Q28248384 |
| | Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 |
| | HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 |
| | Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 |
| | Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. | Q33924728 |
| | The role of p53 in neuronal cell death | Q34201989 |
| | A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder | Q34657883 |
| | Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder | Q34658088 |
| | Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures | Q34696368 |
| | MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines | Q34757887 |
| | Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. | Q35369598 |
| | The p53 family in nervous system development and disease | Q36521923 |
| | Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex | Q37120426 |
| | Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells | Q37706529 |
| | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets | Q38989183 |
| | The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family. | Q39836088 |
| | Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. | Q43496188 |
| | Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants | Q43515220 |
| | The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals | Q43898671 |
| | Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. | Q44121502 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| | genome-wide association study | Q1098876 |
| P304 | page(s) | 1003-1008 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression | |
| P478 | volume | 42 | |